Abstract
Objectivesto evaluate the effects of tofacitinib (TOFA) on cardiovascular risk factors (CVRF) in rheumatoid arthritis (RA) patients (pts).MethodsAfter 12-m follow-up the CVRF dynamic was assessed in 28 RA pts treated...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
